跳至主要内容
临床试验/NL-OMON42203
NL-OMON42203招募中不适用

(Cost-)effectiveness of electronic drug monitoring feedback in order to decrease non-adherence in RA-patients starting with biological DMARD - A randomised clinical trial at Reade - Electronic monitoring feedback of patient*s adherence in rheumatology

Jan van Breemen Instituut0 个研究点目标入组 227 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
227

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Diagnosed with RA (2010 ARA criteria or clinical judgment by a rheumatologist)
  • Initiating a new (subcutaneously administered) bDMARD
  • Sufficient ability to understand Dutch
  • Be able to be followed for 12 months (life expectancy)

排除标准

  • Large cognitive limitations
  • Assistance in taking drugs (e.g. home care)
  • Included in another randomised controlled trial

研究者

发起方
Jan van Breemen Instituut

相似试验